These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29474501)

  • 21. Community pharmacy-based A1c screening: a Canadian model for diabetes care.
    Papastergiou J; Folkins C; Li W
    Int J Pharm Pract; 2016 May; 24(3):189-95. PubMed ID: 26670476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility, accessibility and acceptability a pharmacist-led ear health intervention at rural community pharmacies (LISTEN UP): a mixed-methods study in Queensland, Australia.
    Taylor S; Cairns A; Glass BD
    BMJ Open; 2022 Apr; 12(4):e057011. PubMed ID: 35365533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Availability and analytical quality of hemoglobin A1c point-of-care testing in general practitioners' offices are associated with better glycemic control in type 2 diabetes.
    Tollånes MC; Jenum AK; Berg TJ; Løvaas KF; Cooper JG; Sandberg S
    Clin Chem Lab Med; 2020 Jul; 58(8):1349-1356. PubMed ID: 32229656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of two methods for assessing diabetes risk in a pharmacy setting in Australia.
    Kilkenny MF; Johnson R; Andrew NE; Purvis T; Hicks A; Colagiuri S; Cadilhac DA
    BMC Public Health; 2014 Nov; 14():1227. PubMed ID: 25427845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany.
    Berger K; Eickhoff C; Schulz M
    J Clin Pharm Ther; 2005 Feb; 30(1):45-57. PubMed ID: 15659003
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.
    Kelly DV; Kielly J; Hughes C; Gahagan J; Asghari S; Hancock S; Burt K; Smyczek P; Charlton C; Nguyen H
    BMC Public Health; 2020 May; 20(1):639. PubMed ID: 32380978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Community pharmacy type 2 diabetes risk assessment: demographics and risk results.
    Twigg MJ; Wright DJ; Thornley T; Haynes L
    Int J Pharm Pract; 2015 Feb; 23(1):80-2. PubMed ID: 25047239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Community pharmacy-based case finding for COPD in urban and rural settings is feasible and effective.
    Fathima M; Saini B; Foster JM; Armour CL
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2753-2761. PubMed ID: 29075108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diabetes study in Bavaria: known risk factors correlate with an increased level of HbA1c].
    Martin S; Martin E; Klug C; Weinauer F; Landgraf R; Rapp S
    Dtsch Med Wochenschr; 2007 Jun; 132(24):1315-20. PubMed ID: 17551885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pragmatic and scalable strategy using mobile technology to promote sustained lifestyle changes to prevent type 2 diabetes in India-Outcome of screening.
    Priscilla S; Nanditha A; Simon M; Satheesh K; Kumar S; Shetty AS; Snehalatha C; Johnston DG; Godsland IF; Wareham NJ; Ramachandran A
    Diabetes Res Clin Pract; 2015 Dec; 110(3):335-40. PubMed ID: 26547503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of a community pharmacist intervention in diabetes care: a randomized controlled trial.
    Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Giri M
    J Clin Pharm Ther; 2011 Oct; 36(5):602-13. PubMed ID: 21143256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Know your diabetes risk project: Student pharmacists educating adults about diabetes risk in a community pharmacy setting.
    Letassy N; Dennis V; Lyons TJ; Harrison D; Burton M; Kirkpatrick A
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):188-94. PubMed ID: 20199961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of diabetes knowledge, screening and uptake of community diabetes programs in a peri-urban region in Australia.
    Osuagwu UL; Sharma S; Silva D; Saunders J; Pillay J; Piya MK; Simmons D
    Diabetes Metab Syndr; 2021; 15(5):102257. PubMed ID: 34425557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FINDRISK questionnaire combined with HbA1c testing as a potential screening strategy for undiagnosed diabetes in a healthy population.
    Martin E; Ruf E; Landgraf R; Hauner H; Weinauer F; Martin S
    Horm Metab Res; 2011 Oct; 43(11):782-7. PubMed ID: 22009373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient awareness, willingness, and barriers to point-of-care hepatitis C screening in community pharmacy.
    Brewer A; Hanna C; Eckmann L; Schadler A; Divine H
    J Am Pharm Assoc (2003); 2018; 58(4S):S69-S72.e1. PubMed ID: 30006188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Using glycated haemoglobin testing to simplify diabetes screening in remote Aboriginal Australian health care settings.
    Marley JV; Oh MS; Hadgraft NT; Singleton SL; Isaacs K; Atkinson DN
    Med J Aust; 2015 Jul; 203(1):28-32. PubMed ID: 26126564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experiences and perceptions of foreign-language customers on medication information received in the pharmacy - a focus group study.
    Sletvold H; Nguyen T
    Int J Pharm Pract; 2021 Aug; 29(4):330-335. PubMed ID: 33963846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.